Clinical Trial Update: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating TNK-tPA thrombolysis in acute ischemic stroke (3T Stroke-Ⅲ).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TNK-tPA (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN